Go Pro

American Vanguard (AVD) Competitors

American Vanguard logo
$2.20 +0.02 (+0.92%)
As of 08/28/2026 03:57 PM Eastern

AVD vs. BIOX, SNES, CTVA, NTR, and CF

Should you buy American Vanguard stock or one of its competitors? American Vanguard's main competitors and comparable companies include Bioceres Crop Solutions (BIOX), Senestech (SNES), Corteva (CTVA), Nutrien (NTR), and CF Industries (CF). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "fertilizers & agricultural chemicals" industry.

How does American Vanguard compare to Bioceres Crop Solutions?

American Vanguard (NYSE:AVD) and Bioceres Crop Solutions (NASDAQ:BIOX) are both small-cap materials companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

American Vanguard has a net margin of -10.70% compared to Bioceres Crop Solutions' net margin of -92.85%. American Vanguard's return on equity of -9.05% beat Bioceres Crop Solutions' return on equity.

Company Net Margins Return on Equity Return on Assets
American Vanguard-10.70% -9.05% -2.78%
Bioceres Crop Solutions -92.85%-33.97%-10.31%

79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 17.7% of Bioceres Crop Solutions shares are owned by institutional investors. 5.6% of American Vanguard shares are owned by company insiders. Comparatively, 2.3% of Bioceres Crop Solutions shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

American Vanguard has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market. Comparatively, Bioceres Crop Solutions has a beta of 0.41, suggesting that its share price is 59% less volatile than the broader market.

Bioceres Crop Solutions has a consensus price target of $4.00, suggesting a potential upside of 875.61%. Given Bioceres Crop Solutions' stronger consensus rating and higher possible upside, analysts plainly believe Bioceres Crop Solutions is more favorable than American Vanguard.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Vanguard
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Bioceres Crop Solutions
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

American Vanguard has higher revenue and earnings than Bioceres Crop Solutions. American Vanguard is trading at a lower price-to-earnings ratio than Bioceres Crop Solutions, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Vanguard$515.11M0.13-$49.88M-$1.90N/A
Bioceres Crop Solutions$333.30M0.08-$55.42M-$3.86N/A

In the previous week, Bioceres Crop Solutions had 1 more articles in the media than American Vanguard. MarketBeat recorded 1 mentions for Bioceres Crop Solutions and 0 mentions for American Vanguard. Bioceres Crop Solutions' average media sentiment score of 1.90 beat American Vanguard's score of 0.00 indicating that Bioceres Crop Solutions is being referred to more favorably in the news media.

Company Overall Sentiment
American Vanguard Neutral
Bioceres Crop Solutions Very Positive

Summary

American Vanguard beats Bioceres Crop Solutions on 10 of the 16 factors compared between the two stocks.

How does American Vanguard compare to Senestech?

Senestech (NASDAQ:SNES) and American Vanguard (NYSE:AVD) are both small-cap materials companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, risk, media sentiment, earnings, institutional ownership, valuation, dividends and profitability.

Senestech has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market. Comparatively, American Vanguard has a beta of 1.43, suggesting that its stock price is 43% more volatile than the broader market.

In the previous week, Senestech had 2 more articles in the media than American Vanguard. MarketBeat recorded 2 mentions for Senestech and 0 mentions for American Vanguard. Senestech's average media sentiment score of 0.94 beat American Vanguard's score of 0.00 indicating that Senestech is being referred to more favorably in the media.

Company Overall Sentiment
Senestech Positive
American Vanguard Neutral

5.2% of Senestech shares are held by institutional investors. Comparatively, 79.0% of American Vanguard shares are held by institutional investors. 2.2% of Senestech shares are held by company insiders. Comparatively, 5.6% of American Vanguard shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

American Vanguard has a net margin of -10.70% compared to Senestech's net margin of -294.73%. American Vanguard's return on equity of -9.05% beat Senestech's return on equity.

Company Net Margins Return on Equity Return on Assets
Senestech-294.73% -71.89% -51.98%
American Vanguard -10.70%-9.05%-2.78%

Senestech has higher earnings, but lower revenue than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Senestech, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Senestech$2.37M2.47-$6.38M-$1.37N/A
American Vanguard$515.11M0.13-$49.88M-$1.90N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Senestech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
American Vanguard
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

American Vanguard beats Senestech on 7 of the 13 factors compared between the two stocks.

How does American Vanguard compare to Corteva?

American Vanguard (NYSE:AVD) and Corteva (NYSE:CTVA) are both materials companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation.

Corteva has a net margin of 5.66% compared to American Vanguard's net margin of -10.70%. Corteva's return on equity of 10.18% beat American Vanguard's return on equity.

Company Net Margins Return on Equity Return on Assets
American Vanguard-10.70% -9.05% -2.78%
Corteva 5.66%10.18%6.00%

Corteva has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Corteva, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Vanguard$515.11M0.13-$49.88M-$1.90N/A
Corteva$17.81B3.15$1.09B$1.5155.63

Corteva has a consensus target price of $91.50, indicating a potential upside of 8.93%. Given Corteva's stronger consensus rating and higher possible upside, analysts plainly believe Corteva is more favorable than American Vanguard.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Vanguard
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Corteva
0 Sell rating(s)
9 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.61

79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 81.5% of Corteva shares are owned by institutional investors. 5.6% of American Vanguard shares are owned by company insiders. Comparatively, 0.2% of Corteva shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Corteva had 43 more articles in the media than American Vanguard. MarketBeat recorded 43 mentions for Corteva and 0 mentions for American Vanguard. Corteva's average media sentiment score of 1.61 beat American Vanguard's score of 0.00 indicating that Corteva is being referred to more favorably in the news media.

Company Overall Sentiment
American Vanguard Neutral
Corteva Very Positive

American Vanguard has a beta of 1.43, suggesting that its share price is 43% more volatile than the broader market. Comparatively, Corteva has a beta of 0.57, suggesting that its share price is 43% less volatile than the broader market.

Summary

Corteva beats American Vanguard on 14 of the 16 factors compared between the two stocks.

How does American Vanguard compare to Nutrien?

American Vanguard (NYSE:AVD) and Nutrien (NYSE:NTR) are both materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

Nutrien has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than Nutrien, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Vanguard$515.11M0.13-$49.88M-$1.90N/A
Nutrien$28.21B1.25$2.27B$4.9414.91

In the previous week, Nutrien had 38 more articles in the media than American Vanguard. MarketBeat recorded 38 mentions for Nutrien and 0 mentions for American Vanguard. Nutrien's average media sentiment score of 1.21 beat American Vanguard's score of 0.00 indicating that Nutrien is being referred to more favorably in the news media.

Company Overall Sentiment
American Vanguard Neutral
Nutrien Positive

79.0% of American Vanguard shares are held by institutional investors. Comparatively, 63.1% of Nutrien shares are held by institutional investors. 5.6% of American Vanguard shares are held by company insiders. Comparatively, 3.1% of Nutrien shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Nutrien has a consensus target price of $81.58, suggesting a potential upside of 10.78%. Given Nutrien's stronger consensus rating and higher possible upside, analysts plainly believe Nutrien is more favorable than American Vanguard.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Vanguard
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Nutrien
1 Sell rating(s)
3 Hold rating(s)
17 Buy rating(s)
0 Strong Buy rating(s)
2.76

American Vanguard has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market. Comparatively, Nutrien has a beta of 0.61, meaning that its share price is 39% less volatile than the broader market.

Nutrien has a net margin of 8.44% compared to American Vanguard's net margin of -10.70%. Nutrien's return on equity of 8.88% beat American Vanguard's return on equity.

Company Net Margins Return on Equity Return on Assets
American Vanguard-10.70% -9.05% -2.78%
Nutrien 8.44%8.88%4.27%

Summary

Nutrien beats American Vanguard on 13 of the 16 factors compared between the two stocks.

How does American Vanguard compare to CF Industries?

American Vanguard (NYSE:AVD) and CF Industries (NYSE:CF) are both materials companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, earnings, risk, valuation, profitability, media sentiment and analyst recommendations.

CF Industries has a net margin of 27.12% compared to American Vanguard's net margin of -10.70%. CF Industries' return on equity of 24.41% beat American Vanguard's return on equity.

Company Net Margins Return on Equity Return on Assets
American Vanguard-10.70% -9.05% -2.78%
CF Industries 27.12%24.41%13.74%

CF Industries has higher revenue and earnings than American Vanguard. American Vanguard is trading at a lower price-to-earnings ratio than CF Industries, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Vanguard$515.11M0.13-$49.88M-$1.90N/A
CF Industries$7.08B2.69$1.46B$13.499.32

American Vanguard has a beta of 1.43, indicating that its stock price is 43% more volatile than the broader market. Comparatively, CF Industries has a beta of 0.39, indicating that its stock price is 61% less volatile than the broader market.

79.0% of American Vanguard shares are owned by institutional investors. Comparatively, 93.1% of CF Industries shares are owned by institutional investors. 5.6% of American Vanguard shares are owned by insiders. Comparatively, 0.5% of CF Industries shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, CF Industries had 49 more articles in the media than American Vanguard. MarketBeat recorded 49 mentions for CF Industries and 0 mentions for American Vanguard. CF Industries' average media sentiment score of 1.18 beat American Vanguard's score of 0.00 indicating that CF Industries is being referred to more favorably in the news media.

Company Overall Sentiment
American Vanguard Neutral
CF Industries Positive

CF Industries has a consensus price target of $116.56, indicating a potential downside of 7.31%. Given CF Industries' stronger consensus rating and higher possible upside, analysts plainly believe CF Industries is more favorable than American Vanguard.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Vanguard
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
CF Industries
3 Sell rating(s)
10 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
2.30

Summary

CF Industries beats American Vanguard on 15 of the 17 factors compared between the two stocks.

Get American Vanguard News Delivered to You Automatically

Sign up to receive the latest news and ratings for AVD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AVD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AVD vs. The Competition

MetricAmerican VanguardChemicals IndustryMaterials SectorNYSE Exchange
Market Cap$64.61M$11.64B$5.12B$24.19B
Dividend YieldN/A2.86%4.68%3.71%
P/E Ratio-1.1639.9126.3829.99
Price / Sales0.1351.154,453.9219.52
Price / Cash4.7615.2227.1732.24
Price / Book0.363.659.017.67
Net Income-$49.88M$222.56M$154.80M$1.07B
7 Day Performance-5.58%-0.13%6.41%-0.32%
1 Month Performance-10.39%2.76%18.44%1.84%
1 Year Performance-59.33%16.43%47.35%13.37%

American Vanguard Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AVD
American Vanguard
0.6984 of 5 stars
$2.20
+0.9%
N/A-59.3%$64.61M$515.11MN/A800
BIOX
Bioceres Crop Solutions
2.3456 of 5 stars
$0.41
-6.6%
$4.00
+870.9%
-85.3%$27.88M$333.30MN/A500
SNES
Senestech
2.0544 of 5 stars
$1.19
-5.6%
N/A-78.1%$6.83M$2.22MN/A30
CTVA
Corteva
3.9817 of 5 stars
$82.74
+1.2%
$91.50
+10.6%
+13.2%$54.57B$17.40B54.8021,500
NTR
Nutrien
4.5446 of 5 stars
$74.28
-1.3%
$81.58
+9.8%
+27.6%$36.01B$26.89B15.0425,100

Related Companies and Tools


This page (NYSE:AVD) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners